계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Avraham Pharmaceuticals
company
About
Avraham Pharmaceuticals, a pharmaceutical company, develops novel products for the treatment and prevention of neurodegenerative disorders.
- 11 - 50
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $4.50M
- Industries
- Biotechnology,Health Care,Pharmaceutical
- Founded date
- Jan 1, 2010
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Avraham Pharmaceuticals (“Avraham”) is a privately held, emerging pharmaceutical company developing novel products for treatment and/or prevention of neurodegenerative disorders. Founded in 2010, Avraham has raised $9 million to conduct a European Phase II proof-of-concept efficacy trial in patients with Alzheimer's disease, supporting the development of its lead product candidate, ladostigil.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$4.50M
Avraham Pharmaceuticals has raised a total of
$4.50M
in funding over 2 rounds. Their latest funding was raised on
Sep 17, 2014 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 17, 2014 | Series Unknown | $4.50M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Avraham Pharmaceuticals is funded by 1 investors.
Integra LifeSciences
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Integra LifeSciences
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
